Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension



Status:Archived
Conditions:High Blood Pressure (Hypertension), Ocular
Therapuetic Areas:Cardiology / Vascular Diseases, Ophthalmology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:April 2011
End Date:October 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria


This study will evaluate the safety and efficacy of AGN-210669 ophthalmic solution compared
with bimatoprost ophthalmic solution (Lumigan®) as monotherapy and adjunctive therapy in
patients with primary open-angle glaucoma or ocular hypertension.



We found this trial at
1
site
Clinical Trial Facility
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials